This trial is evaluating whether Behavioral Intervention will improve 1 primary outcome and 4 secondary outcomes in patients with Ovary Cancer. Measurement will happen over the course of Post-meeting (Time 3).
This trial requires 225 total participants across 1 different treatment group
This trial involves a single treatment. Behavioral Intervention is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"The histologic term 'carcinoma, ovarian epithelial' is used frequently but has no clear definition. To avoid confusion, we propose that malignant neoplasms which are endometrial-type adenocarcinoma should be referred to as carcinoma, endometrial type (CEC), whereas those with a serous type should be called serous carcinoma. We also propose that tumors of the ovary, fallopian tube, primary peritoneal surface, and mesothelium should be included in the histological term carcinoma, ovarian epithelial." - Anonymous Online Contributor
"The main cause of carcinoma, ovarian epithelial, is related to a combination of factors including genetics, host immune response, environmental exposures, and viral infections. There is no single risk factor for all cases of carcinoma, ovarian epithelial. For those who do develop carcinoma, there are multiple risk factors associated with the disease progressing to malignancy." - Anonymous Online Contributor
"Well-designed studies will clarify whether there are any differences between ovarian cancer cell lines. It should also be determined if there is a difference in survival rates among different types of ovarian cancers." - Anonymous Online Contributor
"A new approach has been proposed to treat carcinoma of the ovary, and this therapy might be effective. Histological analysis of tumor samples obtained before and after chemotherapy showed that the most frequent changes observed were necrosis and apoptosis. Results from a recent clinical trial suggest that a combination regimen of chemotherapy and irradiation would be relevant to treat malignant tumors, such as ovarian carcinomas." - Anonymous Online Contributor
"Behavioral interventions work to change behaviors deemed harmful and can reduce the risk of developing or worsening disease in those at high risk for chronic illness. Behavioral interventions are commonly used to change many health behaviors and are often combined with medication to improve outcomes. As a result, even if an individual chooses not to take a medication, it is possible that he or she will experience positive effects from the behavioral intervention. Results from a recent clinical trial provides evidence that partners can provide support to assist individuals' coping strategies and promote self-care behavior." - Anonymous Online Contributor
"Survival was lower when the disease was detected at an advanced stage; however, prognosis was better when the disease was detected at an early stage. The most important factor influencing survival was FIGO stage." - Anonymous Online Contributor
"In 11 patients treated by TMJ surgery, there was no recurrence of first relapse. However, in one patient who was thought to be cured after TMJ surgery, there were signs of an unresectable tumor in the ipsilateral ovary. While many patients will not develop recurrent disease when treated by TMJ surgery alone, this case highlights the importance of early diagnosis and prompt surgical intervention when possible because the disease may recur in the ipsilateral ovary even without manifesting itself clinically." - Anonymous Online Contributor
"A combined behavioral intervention improved QOL for women with ovarian carcinoma. In particular, increased satisfaction with one's appearance, less interference with daily activities, and better sleep were associated with improved QOL. This intervention could be used as a component of a cancer rehabilitation program to help address patient concerns about QOL." - Anonymous Online Contributor
"Although the study was limited because of its retrospective nature, the data indicate an average interval of 6 months between diagnosis and initial dissemination of carcinoma, and 7 months between dissemination and beginning of chemotherapy." - Anonymous Online Contributor
"The average age of carcinoma, ovarian epithelial tumor patients is 63.2 years. This age range of onset was 64 to 76 yr in most cases. All cancers cause pain; however, carcinoma, ovarian epithelial causes the highest pain severity. There were no significant differences in time of cancer onset, stage, and symptom onset in menopausal women. There was no significant difference in time of disease onset, but the largest number of advanced stages was noted among premenopausal women." - Anonymous Online Contributor
"A variety of interventions have been developed for relapse prevention following exposure therapy for OCD at least since the late 1970s. Research in this domain continues to evolve. Behavioral interventions can be delivered using a range of delivery methods including self-help books, audiotapes, video tapes, and internet-based programs, among others." - Anonymous Online Contributor